Programming immunogenicity of dengue EDIII vaccine antigens using engineered outer membrane vesicles (OMVs)
Dengue is a mosquito-borne viral infection and is more prevalent in the world with no therapeutics and suboptimal vaccine (Dengvaxia) performance against all four serotypes of the dengue virus. Hence, there is an urgent requirement for a non-infectious and non-replicative vaccine candidate that can...
Saved in:
Main Authors: | Srinivas Duvvada, Farhan Ahmed, Rafiq Ahmad Khan, Shaikh Matin Rahim, Saima Naz, Aradhana Mariam Philips, David Putnam, Avery August, Nooruddin Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-08-01
|
Series: | Vaccine: X |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590136225000737 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outer membrane vesicles (OMVs) and their therapeutic potential as anti-infectious agents
by: Mariana Ottaiano Gonçalves, et al.
Published: (2025-09-01) -
Bioengineering Outer-Membrane Vesicles for Vaccine Development: Strategies, Advances, and Perspectives
by: Ayesha Zahid, et al.
Published: (2025-07-01) -
Membrane vesicles from Red Complex bacteria: key players in oral pathogenesis, immune disruption, systemic diseases, and therapeutic insights
by: Venkatramanan Mahendrarajan, et al.
Published: (2025-07-01) -
The Role of Outer Membrane Protein 16 in <i>Brucella</i> Pathogenesis, Vaccine Development, and Diagnostic Applications
by: Lu Zhang, et al.
Published: (2025-06-01) -
Regional molecular epidemiology of dengue and the potential optimization of its control through the use of vaccines. Report of the Arbovirus Committee of the Latin American Society of Pediatric Infectious Diseases, SLIPE
by: Jaime R. Torres, et al.
Published: (2024-12-01)